Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy

Aug. 30, 2017

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

Lilly discovers novel phosphodiesterase PDE1 inhibitors

Aug. 25, 2017

TFAM overexpression rescues sperm defects in infertile mtDNA mutator mice

Aug. 22, 2017

Avadel and Serenity enter into exclusive negotiations for Noctiva

Aug. 18, 2017

Taiho Pharmaceutical begins enrolling patients in phase II study of TAC-302

Aug. 11, 2017

FDA grants orphan drug designation for blisibimod as treatment of IgA nephropathy

Aug. 10, 2017

Clearance for first-in-human study of ORBCEL-M for diabetic kidney disease

Aug. 7, 2017

FDA grants orphan drug designation to OMS-721 for IgA nephropathy

Aug. 7, 2017

Quark Pharmaceuticals reports positive results from QPI-1002 phase II study

July 28, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...